- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Biogen Inc (BIIB)
Index:
- Change Today: $-4.60
- 52 Week High: $182.09
- 52 Week Low: $118.84
- Currency: US Dollars
- Shares Issued: 145.80m
- Volume: 7,310
- Market Cap: $25,638m
- RiskGrade: 259
Latest ShareCast News
Biogen ups forecasts despite weak Alzheimer's drug sales
By Abigail Townsend
Date: Wednesday 20 Oct 2021
(Sharecast News) - Biogen raised its full-year earnings guidance on Wednesday, despite weak sales of breakthrough Alzheimer's drug Aduhelm.
Biogen shares soar as FDA approves Alzheimer's drug
By Abigail Townsend
Date: Tuesday 08 Jun 2021
(Sharecast News) - Shares in Biogen closed nearly 40% higher after the biotech's breakthrough Alzheimer's drug received regulatory approval in the US.
Biogen and Sage ink $1.5bn deal to develop anti-depression treatments
By Alexander Bueso
Date: Friday 27 Nov 2020
(Sharecast News) - Biogen has inked a deal with Sage Therapeutics to jointly develop and sell potentially "breakthrough" treatments for major depressive and movement disorders in the US.
Biogen Inc Market Data
| Currency | US Dollars |
| Share Price | $ 175.84 |
| Change Today | $ -4.60 |
| % Change | -2.55 % |
| 52 Week High | $182.09 |
| 52 Week Low | $118.84 |
| Volume | 7,310 |
| Shares Issued | 145.80m |
| Market Cap | $25,638m |
| RiskGrade | 259 |
What The Brokers Say
| Strong Buy | 8 |
| Buy | 6 |
| Neutral | 20 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 34 |
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
You are here: research
Digital Look Ltd,
10 Lower Thames St,
London EC3R 6EN
10 Lower Thames St,
London EC3R 6EN